肝脏
肝髒
간장
CHINESE HEPATOLOGY
2015年
2期
106-108
,共3页
王立志%肖作汉%孟冈%孙文锦
王立誌%肖作漢%孟岡%孫文錦
왕립지%초작한%맹강%손문금
慢加急性肝衰竭%自发性细菌性腹膜炎%治愈%早期诊断
慢加急性肝衰竭%自髮性細菌性腹膜炎%治愈%早期診斷
만가급성간쇠갈%자발성세균성복막염%치유%조기진단
Acute-on-chronic liver failure%Spontaneous bacterial peritonitis%Cure%Early diagnosis
目的:探讨慢加急性肝衰竭患者合并自发性腹膜炎(SBP)的早期诊断和治疗。方法将慢加急性肝衰竭108例患者分成3组:A 组38例,患者病毒性重症肝炎,尚无 SBP 指征。B 组36例,重症肝炎患者治疗过程中疗效欠佳(反复腹水生长或腹水控制不理想)。C 组34例,治疗过程中出现发热、腹痛、腹肌紧张,腹膜刺激征阳性,腹水迅速增长,利尿剂无效。分别观察各组患者 PCT、CRP 及内毒素的水平变化,腹水培养的阳性率、耐药率及临床治疗转归率。结果3组患者 PCT、CRP 及内毒素水平检测,C 组与 A 组之间比较差异有统计学意义(P <0.05)。B 组同 C 组之间比较差异无统计学意义(P >0.05)。细菌性腹膜炎的发生分别为 A 组10例(26.32%),B 组25例(69.44%)及 C 组32例(94.12%)。腹水培养的阳性病原菌为41株,39株耐药。抗感染治疗后,67例细菌性腹膜炎好转36例(53.73%),治愈15例(22.39%),死亡16例(23.88%)。结论慢加急性肝衰竭患者出现自发性细菌性腹膜炎的发病率较高,早期发现可以控制病情,提高治愈率。
目的:探討慢加急性肝衰竭患者閤併自髮性腹膜炎(SBP)的早期診斷和治療。方法將慢加急性肝衰竭108例患者分成3組:A 組38例,患者病毒性重癥肝炎,尚無 SBP 指徵。B 組36例,重癥肝炎患者治療過程中療效欠佳(反複腹水生長或腹水控製不理想)。C 組34例,治療過程中齣現髮熱、腹痛、腹肌緊張,腹膜刺激徵暘性,腹水迅速增長,利尿劑無效。分彆觀察各組患者 PCT、CRP 及內毒素的水平變化,腹水培養的暘性率、耐藥率及臨床治療轉歸率。結果3組患者 PCT、CRP 及內毒素水平檢測,C 組與 A 組之間比較差異有統計學意義(P <0.05)。B 組同 C 組之間比較差異無統計學意義(P >0.05)。細菌性腹膜炎的髮生分彆為 A 組10例(26.32%),B 組25例(69.44%)及 C 組32例(94.12%)。腹水培養的暘性病原菌為41株,39株耐藥。抗感染治療後,67例細菌性腹膜炎好轉36例(53.73%),治愈15例(22.39%),死亡16例(23.88%)。結論慢加急性肝衰竭患者齣現自髮性細菌性腹膜炎的髮病率較高,早期髮現可以控製病情,提高治愈率。
목적:탐토만가급성간쇠갈환자합병자발성복막염(SBP)적조기진단화치료。방법장만가급성간쇠갈108례환자분성3조:A 조38례,환자병독성중증간염,상무 SBP 지정。B 조36례,중증간염환자치료과정중료효흠가(반복복수생장혹복수공제불이상)。C 조34례,치료과정중출현발열、복통、복기긴장,복막자격정양성,복수신속증장,이뇨제무효。분별관찰각조환자 PCT、CRP 급내독소적수평변화,복수배양적양성솔、내약솔급림상치료전귀솔。결과3조환자 PCT、CRP 급내독소수평검측,C 조여 A 조지간비교차이유통계학의의(P <0.05)。B 조동 C 조지간비교차이무통계학의의(P >0.05)。세균성복막염적발생분별위 A 조10례(26.32%),B 조25례(69.44%)급 C 조32례(94.12%)。복수배양적양성병원균위41주,39주내약。항감염치료후,67례세균성복막염호전36례(53.73%),치유15례(22.39%),사망16례(23.88%)。결론만가급성간쇠갈환자출현자발성세균성복막염적발병솔교고,조기발현가이공제병정,제고치유솔。
Objective To explore the early diagnosis and therapy of acute-on-chronic liver failure (ACLF)patients complicated with spontaneous bacterial peritonitis (SBP).Methods Serum calcitonin (PCT),C-reactive protein (CRP)and endotoxin were detected in all of 108acute-on-chronic liver failure patients complicated with or without SBP.For the former patients,ascites,conventional culture and drug sensitive test would be carried out.All patients were divided into three groups:group A (38 cases,patients with severe viral hepatitis,no indication of SBP),group B (36 cases,poor curative effect in patients with severe hepatitis treatment process which showed recurrent ascites growth or ascites poor controlled), and group C (34 cases,patients with fever,abdominal pain,abdominal muscle tension,positive peritoneal irritation,ascites rapid increased with diuretics therapy invalid in the process of treatment).Results PCT,CRP and endotoxin were detected.The difference between group A and group C was statistically significant (P <0.05 ),while difference between group B and group C showed no statistical significant (P >0.05 ).Ten cases of bacterial peritonitis incidence (10/38, 26.32%),25 cases (25/36,69.44%)and 32 cases (32/34,94.12%)were found in the three groups,respectively.Forty-one strains of positive pathogens were detected in the ascites cultivate patients,of which positive rate was 58.57% (41/70,).Furthermore,39 strains were drug-resistant bacteria (39/41 ,95.12%).After anti-infectious treatment,clinical symptoms were improved in 36 cases (36/67,53.73%),15 cases were cured (15/67,22.39%),while 16 cases died (16/67,23.88%).Conclusion Incidence of SBP in ACLF patients is higher,and early diagnosis and treatment could improve the prognosis.